Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Huang

Showing results (191-200 of 229) with videos related to

Pageof 23
Sort By:
American Journal of Clinical Oncology|October 29, 2014
Phase I Dose-Escalation Study of Weekly Paclitaxel and Cisplatin Followed by Radical Hysterectomy in Stages IB2 and IIA2 Cervical CancerHung-Hsueh Chou, Huei-Jean Huang, Hao Lin, et al.
Journal of Personalized Medicine|February 25, 2022
MicroRNAs as Predictors of Future Uterine Malignancy in Endometrial Hyperplasia without AtypiaChiao-Yun Lin, Ren-Chin Wu, Lan-Yan Yang, et al.
Journal of Molecular Medicine (Berlin, Germany)|July 9, 2020
Synergistic effects of pazopanib and hyperthermia against uterine leiomyosarcoma growth mediated by downregulation of histone acetyltransferase 1Chiao-Yun Lin, Angel Chao, Ren-Chin Wu, et al.
International Journal of Cancer|November 19, 2011
Human papillomavirus in vaginal intraepithelial neoplasiaAngel Chao, Tse-Ching Chen, Chuen Hsueh, et al.
International Journal of Cancer|May 18, 2010
Human papillomavirus genotype in cervical intraepithelial neoplasia grades 2 and 3 of Taiwanese womenAngel Chao, Mei-Shan Jao, Chu-Chun Huang, et al.
The Journal of Trauma|December 21, 2011
Early parenchymal contrast extravasation predicts subsequent hemorrhage progression, clinical deterioration, and need for surgery in patients with traumatic cerebral contusionAbel Po-Hao Huang, Chung-Wei Lee, Hong-Jen Hsieh, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|May 13, 2021
Postoperative adjuvant dose-dense chemotherapy with bevacizumab and maintenance bevacizumab after neoadjuvant chemotherapy for advanced ovarian cancer: A phase II AGOG/TGOG trialHung-Hsueh Chou, Wei-Chun Chen, Lan-Yan Yang, et al.
International Journal of Cancer|July 16, 2008
Host and viral factors in relation to clearance of human papillomavirus infection: a cohort study in TaiwanChyong-Huey Lai, Angel Chao, Chee-Jen Chang, et al.
Journal of Molecular Medicine (Berlin, Germany)|May 5, 2018
Genomic scar signatures associated with homologous recombination deficiency predict adverse clinical outcomes in patients with ovarian clear cell carcinomaAngel Chao, Chyong-Huey Lai, Tzu-Hao Wang, et al.
International Journal of Cancer|July 24, 2024
Human papillomavirus prevalence, genotype distribution, and prognostic factors of vaginal cancerHsiu-Jung Tung, You-Chen Wang, Chiao-Yun Lin, et al.
Pageof 23

Showing results (191-200 of 229) with videos related to

Sort By:
Pageof 23
American Journal of Clinical Oncology|October 29, 2014
Phase I Dose-Escalation Study of Weekly Paclitaxel and Cisplatin Followed by Radical Hysterectomy in Stages IB2 and IIA2 Cervical CancerHung-Hsueh Chou, Huei-Jean Huang, Hao Lin, et al.
Journal of Personalized Medicine|February 25, 2022
MicroRNAs as Predictors of Future Uterine Malignancy in Endometrial Hyperplasia without AtypiaChiao-Yun Lin, Ren-Chin Wu, Lan-Yan Yang, et al.
Journal of Molecular Medicine (Berlin, Germany)|July 9, 2020
Synergistic effects of pazopanib and hyperthermia against uterine leiomyosarcoma growth mediated by downregulation of histone acetyltransferase 1Chiao-Yun Lin, Angel Chao, Ren-Chin Wu, et al.
International Journal of Cancer|November 19, 2011
Human papillomavirus in vaginal intraepithelial neoplasiaAngel Chao, Tse-Ching Chen, Chuen Hsueh, et al.
International Journal of Cancer|May 18, 2010
Human papillomavirus genotype in cervical intraepithelial neoplasia grades 2 and 3 of Taiwanese womenAngel Chao, Mei-Shan Jao, Chu-Chun Huang, et al.
The Journal of Trauma|December 21, 2011
Early parenchymal contrast extravasation predicts subsequent hemorrhage progression, clinical deterioration, and need for surgery in patients with traumatic cerebral contusionAbel Po-Hao Huang, Chung-Wei Lee, Hong-Jen Hsieh, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|May 13, 2021
Postoperative adjuvant dose-dense chemotherapy with bevacizumab and maintenance bevacizumab after neoadjuvant chemotherapy for advanced ovarian cancer: A phase II AGOG/TGOG trialHung-Hsueh Chou, Wei-Chun Chen, Lan-Yan Yang, et al.
International Journal of Cancer|July 16, 2008
Host and viral factors in relation to clearance of human papillomavirus infection: a cohort study in TaiwanChyong-Huey Lai, Angel Chao, Chee-Jen Chang, et al.
Journal of Molecular Medicine (Berlin, Germany)|May 5, 2018
Genomic scar signatures associated with homologous recombination deficiency predict adverse clinical outcomes in patients with ovarian clear cell carcinomaAngel Chao, Chyong-Huey Lai, Tzu-Hao Wang, et al.
International Journal of Cancer|July 24, 2024
Human papillomavirus prevalence, genotype distribution, and prognostic factors of vaginal cancerHsiu-Jung Tung, You-Chen Wang, Chiao-Yun Lin, et al.
Pageof 23